Manchester Capital Management LLC Invitae Corp Transaction History

Manchester Capital Management LLC

  • $833 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
SELL
$1.2 - $2.73 $434 - $988
-362 Reduced 39.65%
551 $0
Q4 2022

Feb 09, 2023
BUY
$1.71 - $3.61 $198 - $418
116 Added 14.55%
913 $1,000
Q3 2022

Nov 08, 2022
SELL
$1.9 - $8.63 $621 - $2,822
-327 Reduced 29.09%
797 $2,000
Q2 2022

Aug 10, 2022
BUY
$2.13 - $9.01 $2,394 - $10,127
1,124 New
1,124 $3,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email